TY - JOUR
T1 - Study of body fluid samples using flow cytometry
T2 - Six years of experience at the Hospital Universitario San Ignacio - Pontificia Universidad Javeriana, Bogota - Colombia
AU - Campos, Alba
AU - Trujillo, Laura
AU - López, Derly
AU - Beltrán, Lina
AU - Arias, Eliana
AU - Vélez, Graciela
AU - Infante, Antonia
AU - De Los Reyes, Iliana
AU - Vizcaíno, Martha
AU - Guzmán, Paula Carolina
AU - Herrera, Maria Victoria
AU - Solano, Julio
AU - Londoño, Dario
AU - Cañas, Alejandra
AU - Pretelt, Felipe
AU - Pérez, Juan Carlos
AU - Cardozo, Claudia
AU - Fiorentino, Susana
AU - Quijano, Sandra
N1 - Funding Information:
The authors appreciate the financial support provided by the Pontificia Universidad
PY - 2017
Y1 - 2017
N2 - Flow cytometry (FCM) was implemented in 2008 at the Pontificia Universidad Javeriana and later at the Hospital Universitario San Ignacio to examine special samples of patients with hematological malignancies and solid tumors other than bone marrow and peripheral blood for diagnosis and monitoring. This study describes the main findings of special sample evaluation over a six-year period. In all, 1070 samples of body fluids from patients with benign and malignant diseases were examined by FCM. These samples were stabilized with TransFixTM and stained with six-color immunophenotyping panels. Samples included cerebrospinal fluid, bronchoalveolar lavage, pleural fluid, pericardial fluid and ascite fluid from patients with acute and chronic leukemia, myelodysplastic syndromes, lymphomas, myeloma, autoimmune diseases, immunodeficiencies and solid tumors, among others. Flow cytometry provided important information for the classification and detection of minimal numbers of tumor cells in leukemia and lymphoma cases. This work represents the first national report describing FCM implementation in special samples for diagnosis and clinical monitoring of patients with malignant and benign pathologies.
AB - Flow cytometry (FCM) was implemented in 2008 at the Pontificia Universidad Javeriana and later at the Hospital Universitario San Ignacio to examine special samples of patients with hematological malignancies and solid tumors other than bone marrow and peripheral blood for diagnosis and monitoring. This study describes the main findings of special sample evaluation over a six-year period. In all, 1070 samples of body fluids from patients with benign and malignant diseases were examined by FCM. These samples were stabilized with TransFixTM and stained with six-color immunophenotyping panels. Samples included cerebrospinal fluid, bronchoalveolar lavage, pleural fluid, pericardial fluid and ascite fluid from patients with acute and chronic leukemia, myelodysplastic syndromes, lymphomas, myeloma, autoimmune diseases, immunodeficiencies and solid tumors, among others. Flow cytometry provided important information for the classification and detection of minimal numbers of tumor cells in leukemia and lymphoma cases. This work represents the first national report describing FCM implementation in special samples for diagnosis and clinical monitoring of patients with malignant and benign pathologies.
KW - Body fluids
KW - Flow cytometry
KW - Immunophenotype
UR - http://www.scopus.com/inward/record.url?scp=85028397588&partnerID=8YFLogxK
U2 - 10.11144/Javeriana.SC22-2.sobf
DO - 10.11144/Javeriana.SC22-2.sobf
M3 - Article
AN - SCOPUS:85028397588
SN - 0122-7483
VL - 22
SP - 123
EP - 143
JO - Universitas Scientiarum
JF - Universitas Scientiarum
IS - 2
ER -